Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Kedudukan dalam Saham #30395
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Harga Saham
$0.03834
Disegerakkan terakhir: 2026-08-18
Modal Pasaran
$17.01M
Perubahan (1 hari)
-4.15%
Perubahan (1 tahun)
-24.82%
Negara
US
Perdagangan Oncotelic Therapeutics, Inc. (OTLC)

Kategori

Sejarah pecahan saham untuk Oncotelic Therapeutics, Inc. (OTLC)
Saham Oncotelic Therapeutics, Inc. (simbol: OTLC) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 19, 2026.
Satu saham OTLC yang dibeli sebelum Aug 19, 2026 kini bersamaan dengan 0 saham OTLC.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE